TITLE

Current concepts in the pathophysiology of glaucoma

AUTHOR(S)
Agarwal, Renu; Gupta, Suresh K.; Agarwal, Puneet; Saxena, Rohit; Agrawal, Shyam S.
PUB. DATE
September 2009
SOURCE
Indian Journal of Ophthalmology;Sep2009, Vol. 57 Issue 4, p257
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Glaucoma, the second leading cause of blindness, is characterized by changes in the optic disc and visual field defects. The elevated intraocular pressure was considered the prime factor responsible for the glaucomatous optic neuropathy involving death of retinal ganglion cells and their axons. Extensive investigations into the pathophysiology of glaucoma now reveal the role of multiple factors in the development of retinal ganglion cell death. A better understanding of the pathophysiological mechanisms involved in the onset and progression of glaucomatous optic neuropathy is crucial in the development of bett er therapeutic options. This review is an eff ort to summarize the current concepts in the pathophysiology of glaucoma so that newer therapeutic targets can be recognized. The literature available in the National Medical Library and online Pubmed search engine was used for literature review.
ACCESSION #
43247860

 

Related Articles

  • Therapeutic Adherence and Persistence in Diagnosed Glaucoma Patients of Optalmologic Hospital's Clinic of Tabriz. Heidari, Fariba; Shenasi, Abdollah; Akbari, Rahman // Medical Journal of Tabriz University of Medical Sciences & Healt;Dec2012-Jan2013, Vol. 34 Issue 5, p11 

    Background and Objectives: Glaucoma is an optic neuropathy characterized by gradual loss of retinal ganglion cells and thinning of the retinal nerve fiber layer. It is the second cause of blindness in the developed world. Glaucoma affects nearly 70 million people worldwide, of which nearly half...

  • New perspectives on glaucoma. Dreyer, Evan Benjamin; Lipton, Stuart A.; Dreyer, E B; Lipton, S A // JAMA: Journal of the American Medical Association;1/27/99, Vol. 281 Issue 4, p306 

    Discusses glaucoma, a leading cause of irreversible blindness. Classic and new theories of glaucomatous damage; The role of excitotoxicity in glaucoma; Therapeutic approaches that may alleviate the ganglion cell loss and blindness that accompany the disease.

  • A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies. Osborne, N. N.; Lascaratos, G.; Bron, A. J.; Chidlow, G.; Wood, J. P. M. // British Journal of Ophthalmology;Feb2006, Vol. 90 Issue 2, p237 

    The authors propose that light entering the eye interacts with retinal ganglion cell (RGC) axon mitochondria to generate reactive oxygen intermediates (ROI) and that when these neurons are in an energetically low state, their capacity to remove these damaging molecules is exceeded and their...

  • Stem cell therapy closer to reality. Krader, Cheryl Guttman // Ophthalmology Times;Jan2011, Vol. 36 Issue 1, p26 

    The article discusses the importance of stem cell therapy as neuronal protection, repair or replacement in restoring glaucoma-related vision loss. It notes that stem cell-based therapy might be used to achieve neuroprotection or for retinal ganglion cell (RGC) replacement or repair. Moreover, it...

  • Is multifocal electroretinography an early predictor of glaucoma? Gölemez, Haydar; Yıldırım, Nilgün; Özer, Ahmet // Documenta Ophthalmologica;Feb2016, Vol. 132 Issue 1, p27 

    Purpose: To investigate the potential use of mfERG as an objective functional test that can express inner and outer retinal changes during the early stages of glaucoma. Methods: One hundred and twenty-six eyes of 126 patients were included. There were 30 healthy (Group 1), 28 glaucoma suspect...

  • Overexpression of Myocilin in the Drosophila Eye Activates the Unfolded Protein Response: Implications for Glaucoma. Carbone, Mary Anna; Ayroles, Julien F.; Yamamoto, Akihiko; Morozova, Tatiana V.; West, Steven A.; Magwire, Michael M.; Mackay, Trudy F. C.; Anholt, Robert R. H. // PLoS ONE;2009, Vol. 4 Issue 1, p1 

    Background: Glaucoma is the world's second leading cause of bilateral blindness with progressive loss of vision due to retinal ganglion cell death. Myocilin has been associated with congenital glaucoma and 2-4% of primary open angle glaucoma (POAG) cases, but the pathogenic mechanisms remain...

  • Connecting the Eye to the Brain. Gupta, Neeru // Ophthalmology Times;5/1/2007 Neuroprotection in Glaucom, Vol. 32, p5 

    The article provides information on topics related to glaucoma. It has been noted that glaucoma is characterized by death of retinal ganglion cells (RGCs) and their axons. Most of the RGC axon exists outside the globe and can be traced to its major target in the lateral geniculare nucleus (LGN)...

  • Glaucoma. Lewis, Thomas L. // Review of Optometry;5/15/2003, Vol. 140 Issue 5, p51 

    Examines the methods of treating glaucoma. Factors predicting visual field loss; Side effects of latanoprost with glaucoma medications; Protection of retinal ganglion cells from death by vaccinations with adjuvant therapy.

  • Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. Schlamp, Cassandra L.; Yan Li; Dietz, Joel A.; Janssen, Katherine T.; Nickells, Robert W. // BMC Neuroscience;2006, Vol. 7, p66 

    Background: Glaucoma is a chronic neurodegenerative disease of the retina, characterized by the degeneration of axons in the optic nerve and retinal ganglion cell apoptosis. DBA/2J inbred mice develop chronic hereditary glaucoma and are an important model system to study the molecular mechanisms...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics